Wire Stories
531New Data Shows Advantages of Rapid Medical’s COMANECI™ Embolization Assist Device
World Neurosurgery meta-analysis shows fewer complications, higher occlusion rates for ruptured wide-neck intracranial aneurysms YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–#Brainaneurysm—Rapid Medicalâ„¢, a leading...
- 539
Renesas Develops Complete Power Management Solution for AMD Space-Grade Versal Adaptive SoC
Reference Design Packs Multiple Rad-Hard Core Power Rails in Ultra-Compact Footprint, Delivering Turnkey Efficiency and Precision TOKYO–(BUSINESS WIRE)–#Renesas–Renesas Electronics Corporation (TSE:6723), a...
- 473
Interactive Brokers Offers Trading on the Taiwan Stock Exchange
IBKR Further Expands Its Global Market Access GREENWICH, Conn.–(BUSINESS WIRE)–Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced access to...
- 586
Cyber Security Startup PingSafe Launches from Stealth with $3.3M to Outsmart Attackers
PingSafe helps companies target their biggest cloud security challenges, providing coverage for exploitable vulnerabilities. In 2022, revenues grew 10x and it has...
- 583
Macnica and Dragos to Deliver OT Cybersecurity to Critical Infrastructure and Manufacturing Control Systems in Japan
HANNOVER, Md. & YOKOHAMA, Japan–(BUSINESS WIRE)–Dragos, the global leader in cybersecurity for Operational Technology (OT), and Macnica Corporation (Headquarters: Yokohama City, Kanagawa...
- 484
Enfusion Announces Date of Second Quarter 2023 Results
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment...
- 532
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
– Key Initiatives Highlight the Role of Catalytic Collaboration to Help Advance Health Equity – – Latest HIV Research and Development Data...
- 531
JAMA Oncology Publishes Data from Zai Lab Study Demonstrating Significant Reduction in Disease Progression or Death with ZEJULA (Niraparib) Maintenance Therapy in Broad Population of Advanced Ovarian Cancer Patients
The Phase 3 PRIME study demonstrates that treatment with ZEJULA significantly extends progression-free survival versus placebo and reduces the risk of disease...
- 541
FPT Software Launches FezyFlow, A No-code Workflow Platform
HANOI, Vietnam–(BUSINESS WIRE)–#FPT–FPT Software, a global IT service provider, announces the official launch of its no-code workflow platform, FezyFlow. With a vision...
- 431
Lookout Discovers Advanced Android Surveillanceware Attributed to China’s APT41
An established threat actor like APT41 turning its focus to mobile devices shows how mobile endpoints are high-value targets with coveted work...
